Jiajun Liu

1.4k total citations
41 papers, 1.0k citations indexed

About

Jiajun Liu is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jiajun Liu has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 11 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Jiajun Liu's work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Jiajun Liu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (22 papers), Antimicrobial Resistance in Staphylococcus (11 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Jiajun Liu collaborates with scholars based in United States, China and Australia. Jiajun Liu's co-authors include Marc H. Scheetz, Nathaniel J. Rhodes, Gwendolyn Pais, Sean N. Avedissian, Biao Li, Xiaopei Shen, Rengyun Liu, Mingzhao Xing, J. Nicholas O’Donnell and Guangwu Zhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Clinical Infectious Diseases.

In The Last Decade

Jiajun Liu

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiajun Liu United States 16 427 233 193 192 176 41 1.0k
Edith Lackner Austria 19 442 1.0× 232 1.0× 49 0.3× 167 0.9× 167 0.9× 46 1.4k
Hjalmar Lagast Belgium 17 242 0.6× 177 0.8× 415 2.2× 153 0.8× 155 0.9× 48 1.2k
Veronique Stove Belgium 25 985 2.3× 544 2.3× 120 0.6× 353 1.8× 158 0.9× 81 2.0k
Fleur Wolff Belgium 16 393 0.9× 222 1.0× 62 0.3× 121 0.6× 319 1.8× 49 931
Hassan Gandjini France 10 374 0.9× 356 1.5× 41 0.2× 506 2.6× 164 0.9× 14 1.1k
Raül Rigo‐Bonnin Spain 14 261 0.6× 149 0.6× 37 0.2× 219 1.1× 101 0.6× 78 741
Luis M. Beltrán Spain 16 135 0.3× 254 1.1× 39 0.2× 337 1.8× 71 0.4× 50 1.1k
Melisa Cooper United Kingdom 12 270 0.6× 166 0.7× 117 0.6× 159 0.8× 55 0.3× 20 583
Stéphanie Ruiz France 18 324 0.8× 379 1.6× 118 0.6× 135 0.7× 129 0.7× 46 997
I‐Jung Tsai Taiwan 20 158 0.4× 199 0.9× 251 1.3× 32 0.2× 245 1.4× 78 1.3k

Countries citing papers authored by Jiajun Liu

Since Specialization
Citations

This map shows the geographic impact of Jiajun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajun Liu more than expected).

Fields of papers citing papers by Jiajun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajun Liu. The network helps show where Jiajun Liu may publish in the future.

Co-authorship network of co-authors of Jiajun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajun Liu. A scholar is included among the top collaborators of Jiajun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajun Liu. Jiajun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pais, Gwendolyn, Jiajun Liu, Jack Chang, et al.. (2023). Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model. British Journal of Pharmacology. 181(5). 670–680. 2 indexed citations
3.
Chang, Jack, Jiajun Liu, Mohammad H. Al‐Shaer, et al.. (2023). Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults. Journal of Antimicrobial Chemotherapy. 78(9). 2170–2174. 3 indexed citations
4.
Locci, Emanuela, Jiajun Liu, Gwendolyn Pais, et al.. (2022). Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury. International Journal of Antimicrobial Agents. 60(1). 106593–106593. 4 indexed citations
5.
Pais, Gwendolyn, Jack Chang, Jiajun Liu, & Marc H. Scheetz. (2022). A translational rat model to assess glomerular function changes with vancomycin. International Journal of Antimicrobial Agents. 59(5). 106583–106583. 8 indexed citations
6.
Scheetz, Marc H., Gwendolyn Pais, Thomas P. Lodise, et al.. (2021). Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships. Antimicrobial Agents and Chemotherapy. 65(10). e0106021–e0106021. 10 indexed citations
7.
Liu, Jiajun, Michael Neely, Jeffrey Lipman, et al.. (2020). Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime. Clinical Pharmacokinetics. 59(8). 1027–1036. 9 indexed citations
8.
Liu, Jiajun, Gwendolyn Pais, Sean N. Avedissian, et al.. (2020). Evaluation of Dose-Fractionated Polymyxin B on Acute Kidney Injury Using a Translational In Vivo Rat Model. Antimicrobial Agents and Chemotherapy. 64(5). 6 indexed citations
9.
Avedissian, Sean N., Gwendolyn Pais, Jiajun Liu, et al.. (2020). The Pharmacodynamic-Toxicodynamic Relationship of AUC and C max in Vancomycin-Induced Kidney Injury in an Animal Model. Antimicrobial Agents and Chemotherapy. 65(3). 15 indexed citations
10.
Pais, Gwendolyn, Jiajun Liu, Sean N. Avedissian, et al.. (2020). Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(5). 438–454. 50 indexed citations
11.
Liu, Jiajun, et al.. (2020). QTL mapping of pericarp and fruit-related traits in melon (Cucumis melo L.) using SNP-derived CAPS markers. Scientia Horticulturae. 265. 109243–109243. 14 indexed citations
12.
Avedissian, Sean N., Gwendolyn Pais, Jiajun Liu, Nathaniel J. Rhodes, & Marc H. Scheetz. (2019). Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?. Clinical Infectious Diseases. 71(2). 426–432. 36 indexed citations
13.
Pais, Gwendolyn, Jiajun Liu, Sean N. Avedissian, et al.. (2019). Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model. Journal of Antimicrobial Chemotherapy. 75(5). 1228–1236. 38 indexed citations
14.
Jiang, Wei, Jiajun Liu, Yuhua Qiu, et al.. (2019). Significant benefit of nivolumab combining radiotherapy in metastatic gallbladder cancer patient with strong PD-L1 expression: a case report. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Bai, Tao, Guo Chen, Jiajun Liu, et al.. (2019). Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Downes, Kevin J., Molly Hayes, Julie C. Fitzgerald, et al.. (2019). Mechanisms of antimicrobial-induced nephrotoxicity in children. Journal of Antimicrobial Chemotherapy. 75(1). 1–13. 58 indexed citations
17.
Li, Qian, Xiaohui Ning, Brett J. Stanley, et al.. (2018). Reliable Analysis of the Interaction between Specific Ligands and Immobilized Beta-2-Adrenoceptor by Adsorption Energy Distribution. Analytical Chemistry. 90(13). 7903–7911. 32 indexed citations
18.
Rhodes, Nathaniel J., Jiajun Liu, J. Nicholas O’Donnell, et al.. (2017). Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis*. Critical Care Medicine. 46(2). 236–243. 83 indexed citations
19.
Rhodes, Nathaniel J., Jiajun Liu, Milena M. McLaughlin, Chao Qi, & Marc H. Scheetz. (2015). Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC. Diagnostic Microbiology and Infectious Disease. 82(2). 165–171. 18 indexed citations
20.
He, Yi, et al.. (2012). Decitabine application combined with allogeneic hematopoietic stem cell transplantation for treatment of acute leukemia progressed from myelodysplastic syndrome. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 9253–9256.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edith Lackner Breakdown of academic impact, for papers by Hjalmar Lagast Breakdown of academic impact, for papers by Veronique Stove Breakdown of academic impact, for papers by Fleur Wolff Breakdown of academic impact, for papers by Hassan Gandjini Breakdown of academic impact, for papers by Raül Rigo‐Bonnin Breakdown of academic impact, for papers by Luis M. Beltrán Breakdown of academic impact, for papers by Melisa Cooper Breakdown of academic impact, for papers by Stéphanie Ruiz Breakdown of academic impact, for papers by I‐Jung Tsai
Rankless by CCL
2026